Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1410
-
Total 13F shares, excl. options
-
213M
-
Shares change
-
+136K
-
Total reported value, excl. options
-
$103B
-
Value change
-
-$37M
-
Put/Call ratio
-
1.1
-
Number of buys
-
628
-
Number of sells
-
-594
-
Price
-
$482.58
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2022
1,568 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2022.
Elevance Health, Inc. - Common Stock (ELV) has 1,410 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 213M shares
of 226M outstanding shares and own 94.35% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21.8M shares), VANGUARD GROUP INC (21.1M shares), STATE STREET CORP (10.8M shares), WELLINGTON MANAGEMENT GROUP LLP (9.85M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.46M shares), FMR LLC (6.55M shares), Capital International Investors (6.42M shares), BANK OF AMERICA CORP /DE/ (4.66M shares), GEODE CAPITAL MANAGEMENT, LLC (4.13M shares), and Sanders Capital, LLC (4.08M shares).
This table shows the top 1410 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.